306 related articles for article (PubMed ID: 28511006)
1. Novel Focused Ultrasound Gene Therapy Approach Noninvasively Restores Dopaminergic Neuron Function in a Rat Parkinson's Disease Model.
Mead BP; Kim N; Miller GW; Hodges D; Mastorakos P; Klibanov AL; Mandell JW; Hirsh J; Suk JS; Hanes J; Price RJ
Nano Lett; 2017 Jun; 17(6):3533-3542. PubMed ID: 28511006
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive, neuron-specific gene therapy by focused ultrasound-induced blood-brain barrier opening in Parkinson's disease mouse model.
Lin CY; Hsieh HY; Chen CM; Wu SR; Tsai CH; Huang CY; Hua MY; Wei KC; Yeh CK; Liu HL
J Control Release; 2016 Aug; 235():72-81. PubMed ID: 27235980
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologically controlled, discontinuous GDNF gene therapy restores motor function in a rat model of Parkinson's disease.
Tereshchenko J; Maddalena A; Bähr M; Kügler S
Neurobiol Dis; 2014 May; 65():35-42. PubMed ID: 24440408
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive, Targeted, and Non-Viral Ultrasound-Mediated GDNF-Plasmid Delivery for Treatment of Parkinson's Disease.
Fan CH; Ting CY; Lin CY; Chan HL; Chang YC; Chen YY; Liu HL; Yeh CK
Sci Rep; 2016 Jan; 6():19579. PubMed ID: 26786201
[TBL] [Abstract][Full Text] [Related]
5. Efficient gene therapy for Parkinson's disease using astrocytes as hosts for localized neurotrophic factor delivery.
Drinkut A; Tereshchenko Y; Schulz JB; Bähr M; Kügler S
Mol Ther; 2012 Mar; 20(3):534-43. PubMed ID: 22086235
[TBL] [Abstract][Full Text] [Related]
6. Gene Therapy in the Management of Parkinson's Disease: Potential of GDNF as a Promising Therapeutic Strategy.
Behl T; Kaur I; Kumar A; Mehta V; Zengin G; Arora S
Curr Gene Ther; 2020; 20(3):207-222. PubMed ID: 32811394
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound-responsive neurotrophic factor-loaded microbubble- liposome complex: Preclinical investigation for Parkinson's disease treatment.
Lin CY; Lin YC; Huang CY; Wu SR; Chen CM; Liu HL
J Control Release; 2020 May; 321():519-528. PubMed ID: 32112852
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-triggered effects of the microbubbles coupled to GDNF- and Nurr1-loaded PEGylated liposomes in a rat model of Parkinson's disease.
Yue P; Gao L; Wang X; Ding X; Teng J
J Cell Biochem; 2018 Jun; 119(6):4581-4591. PubMed ID: 29240240
[TBL] [Abstract][Full Text] [Related]
9. Co-transplantation of GDNF-overexpressing neural stem cells and fetal dopaminergic neurons mitigates motor symptoms in a rat model of Parkinson's disease.
Deng X; Liang Y; Lu H; Yang Z; Liu R; Wang J; Song X; Long J; Li Y; Lei D; Feng Z
PLoS One; 2013; 8(12):e80880. PubMed ID: 24312503
[TBL] [Abstract][Full Text] [Related]
10. SINEUP Non-coding RNA Targeting GDNF Rescues Motor Deficits and Neurodegeneration in a Mouse Model of Parkinson's Disease.
Espinoza S; Scarpato M; Damiani D; Managò F; Mereu M; Contestabile A; Peruzzo O; Carninci P; Santoro C; Papaleo F; Mingozzi F; Ronzitti G; Zucchelli S; Gustincich S
Mol Ther; 2020 Feb; 28(2):642-652. PubMed ID: 31495777
[TBL] [Abstract][Full Text] [Related]
11. Glial cell line-derived neurotrophic factor partially ameliorates motor symptoms without slowing neurodegeneration in mice with respiratory chain-deficient dopamine neurons.
Sterky FH; Pernold K; Harvey BK; Lindqvist E; Hoffer BJ; Olson L
Cell Transplant; 2013; 22(9):1529-39. PubMed ID: 23051605
[TBL] [Abstract][Full Text] [Related]
12. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
[TBL] [Abstract][Full Text] [Related]
13. Targeted gene transfer to the brain via the delivery of brain-penetrating DNA nanoparticles with focused ultrasound.
Mead BP; Mastorakos P; Suk JS; Klibanov AL; Hanes J; Price RJ
J Control Release; 2016 Feb; 223():109-117. PubMed ID: 26732553
[TBL] [Abstract][Full Text] [Related]
14. GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop.
Barker RA; Björklund A; Gash DM; Whone A; Van Laar A; Kordower JH; Bankiewicz K; Kieburtz K; Saarma M; Booms S; Huttunen HJ; Kells AP; Fiandaca MS; Stoessl AJ; Eidelberg D; Federoff H; Voutilainen MH; Dexter DT; Eberling J; Brundin P; Isaacs L; Mursaleen L; Bresolin E; Carroll C; Coles A; Fiske B; Matthews H; Lungu C; Wyse RK; Stott S; Lang AE
J Parkinsons Dis; 2020; 10(3):875-891. PubMed ID: 32508331
[TBL] [Abstract][Full Text] [Related]
15. Glial cell line-derived neurotrophic factor receptor Rearranged during transfection agonist supports dopamine neurons in Vitro and enhances dopamine release In Vivo.
Mahato AK; Kopra J; Renko JM; Visnapuu T; Korhonen I; Pulkkinen N; Bespalov MM; Domanskyi A; Ronken E; Piepponen TP; Voutilainen MH; Tuominen RK; Karelson M; Sidorova YA; Saarma M
Mov Disord; 2020 Feb; 35(2):245-255. PubMed ID: 31840869
[TBL] [Abstract][Full Text] [Related]
16. Potential Therapeutic Approach using Aromatic l-amino Acid Decarboxylase and Glial-derived Neurotrophic Factor Therapy Targeting Putamen in Parkinson's Disease.
Tripathi RK; Goyal L; Singh S
Curr Gene Ther; 2024; 24(4):278-291. PubMed ID: 38310455
[TBL] [Abstract][Full Text] [Related]
17. Long-term benefits of hematopoietic stem cell-based macrophage/microglia delivery of GDNF to the CNS in a mouse model of Parkinson's disease.
Ge G; Sivasubramanian BP; Geng BD; Zhao S; Zhou Q; Huang G; O'Connor JC; Clark RA; Li S
Gene Ther; 2024 May; 31(5-6):324-334. PubMed ID: 38627469
[TBL] [Abstract][Full Text] [Related]
18. Transgenic expression of human glial cell line-derived neurotrophic factor from integration-deficient lentiviral vectors is neuroprotective in a rodent model of Parkinson's disease.
Lu-Nguyen NB; Broadstock M; Schliesser MG; Bartholomae CC; von Kalle C; Schmidt M; Yáñez-Muñoz RJ
Hum Gene Ther; 2014 Jul; 25(7):631-41. PubMed ID: 24635742
[TBL] [Abstract][Full Text] [Related]
19. Glial-derived neurotrophic factor gene transfer for Parkinson's disease: anterograde distribution of AAV2 vectors in the primate brain.
Kells AP; Forsayeth J; Bankiewicz KS
Neurobiol Dis; 2012 Nov; 48(2):228-35. PubMed ID: 22019719
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease.
Sun M; Kong L; Wang X; Lu XG; Gao Q; Geller AI
Brain Res; 2005 Aug; 1052(2):119-29. PubMed ID: 16018990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
